These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24134931)

  • 1. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
    Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract.
    Gulmann C; Paner GP; Parakh RS; Hansel DE; Shen SS; Ro JY; Annaiah C; Lopez-Beltran A; Rao P; Arora K; Cho Y; Herrera-Hernandez L; Alsabeh R; Amin MB
    Hum Pathol; 2013 Feb; 44(2):164-72. PubMed ID: 22995333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
    Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE
    Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
    Esheba GE; Longacre TA; Atkins KA; Higgins JP
    Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
    Fatima N; Osunkoya AO
    Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas.
    Liu H; Shi J; Wilkerson ML; Lin F
    Am J Clin Pathol; 2012 Jul; 138(1):57-64. PubMed ID: 22706858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.
    Paner GP; Annaiah C; Gulmann C; Rao P; Ro JY; Hansel DE; Shen SS; Lopez-Beltran A; Aron M; Luthringer DJ; De Peralta-Venturina M; Cho Y; Amin MB
    Hum Pathol; 2014 Jul; 45(7):1473-82. PubMed ID: 24780825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
    Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.
    Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS
    Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
    Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
    Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens.
    Brandler TC; Aziz MS; Rosen LM; Bhuiya TA; Yaskiv O
    Cancer Cytopathol; 2014 Jun; 122(6):468-73. PubMed ID: 24711443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis.
    Brimo F; Herawi M; Sharma R; Netto GJ; Epstein JI; Illei PB
    Hum Pathol; 2011 Nov; 42(11):1613-9. PubMed ID: 21496868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.
    Hoang LL; Tacha D; Bremer RE; Haas TS; Cheng L
    Appl Immunohistochem Mol Morphol; 2015; 23(10):711-6. PubMed ID: 25611245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial tumors with villous morphology: Histomorphology and role of immunohistochemistry in diagnosis.
    Mitra S; Chatterjee D; Das A; Gupta K; Radotra BD; Mandal AK
    APMIS; 2018 Mar; 126(3):191-200. PubMed ID: 29399882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of GATA-3 in urothelial carcinoma variants.
    Liang Y; Heitzman J; Kamat AM; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2014 Jul; 45(7):1466-72. PubMed ID: 24745616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor.
    Han AC; Duszak R
    Cancer; 1999 Dec; 86(11):2327-30. PubMed ID: 10590374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.